The Setup
Every quarter, biotech-only hedge funds — the ones that live and die by clinical readouts — quietly tell you what they think will work over the next 24 months. You just have to read 13Fs and resist the temptation to chase whatever oncology name is trending on FinTwit.
This week, the signal is loud and the name is underrated outside the specialis…
